Stairlifts Market: Foresees Skyrocketing Growth in the Coming Years Levodopa Market

Levodopa Industry Analysis, Growth and Forecast, 2018-
2026 - Coherent Market Insights
Levodopa or L-Dopa is a chemical building-block that converts into a dopamine in body.
Dopamine is the chemical messenger released in brain. It mediates pleasure, cognition, and
memory functions. Nearly all patients receive the dopamine precursor levodopa, which
adequately control symptoms of Parkinson's disease (PD) at early stage of the disease. Carbidopa
is often included with levodopa-containing drugs in order to boost its efficacy by slowing down
the metabolism of dopamine.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/2247
Levodopa Market Driver
Development of novel formulations and efficient drug delivery methods for levodopa are
expected to drive growth of the levodopa market. For instance, a clinical study for gastric
retentive Accordion Pill, an immediate drug release formulation by Intec Pharma Ltd., is
ongoing in clinical phase III and is expected to complete in September 2018. Accordion Pill is a
Carbidopa/Levodopa (AP-CD/LD) combinational oral drug delivery system, which is designed to
improve the efficacy and safety of existing CD/LD drugs by utilizing an efficient gastric
retention and specific release mechanism.
Moreover, Impel NeuroPharma Inc. is conducting phase II clinical study for INP103, a drug-
device combination product containing a drug component, L-dopa, and device component I231
Precision Olfactory Delivery (POD) device. The study is expected to complete in November
2018.
Furthermore, advancement in diagnosis of Parkinson's disease (PD) progression is expected to
boost growth of levodopa market. For instance, a clinical study conducted by Washington
University School of Medicine, for measuring PD progression both by using Magnetic Resonance